EP 1859797 A4 20110413 - NOVEL CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT
Title (en)
NOVEL CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT
Title (de)
NEUE GLEICHZEITIGE VERWENDUNG EINER SULFONAMID-VERBINDUNG UND EINES MITTELS GEGEN KREBS
Title (fr)
NOUVELLE UTILISATION CONCOMITANTE D'UN COMPOSE DE SULFONAMIDE AVEC UN AGENT ANTI-CANCER
Publication
Application
Priority
- JP 2006304219 W 20060228
- JP 2005055132 A 20050228
Abstract (en)
[origin: EP1859797A1] The present invention relates to a pharmaceutical composition, a kit, a method of treating cancer and/or a method of inhibiting angiogenesis comprising a sulfonamide compound in combination with a platinum complex, a DNA-topoisomerase I inhibitor, an antimetabolite, a microtubule inhibitor or an antibiotic.
IPC 8 full level
A61K 31/18 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/404 (2006.01); A61K 31/4741 (2006.01); A61K 31/498 (2006.01); A61K 31/7068 (2006.01); A61K 33/243 (2019.01); A61K 45/06 (2006.01); A61P 9/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/18 (2013.01 - EP US); A61K 31/343 (2013.01 - EP US); A61K 31/381 (2013.01 - EP US); A61K 31/404 (2013.01 - EP US); A61K 31/4741 (2013.01 - EP US); A61K 31/498 (2013.01 - EP US); A61K 31/7068 (2013.01 - EP US); A61K 33/243 (2018.12 - EP US); A61K 45/06 (2013.01 - EP US); A61P 9/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
- [XAY] EP 1481678 A1 20041201 - EISAI CO LTD [JP]
- [YA] EP 1331005 A1 20030730 - EISAI CO LTD [JP]
- [YA] WO 2004026872 A1 20040401 - SCHERING CORP [US]
- [A] SHIMIZU K ET AL: "Cancer anti-angiogenic therapy", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP LNKD- DOI:10.1248/BPB.27.599, vol. 27, no. 5, 1 May 2004 (2004-05-01), pages 599 - 605, XP002483110, ISSN: 0918-6158
- [A] FUKUOKA K ET AL: "Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells", INVESTIGATIONAL NEW DRUGS, MARTINUS NIJHOFF PUBLISHERS, BOSTON, US LNKD- DOI:10.1023/A:1010608317361, vol. 19, no. 3, 1 January 2001 (2001-01-01), pages 219 - 227, XP002483112, ISSN: 0167-6997
- See references of WO 2006090931A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
EP 1859797 A1 20071128; EP 1859797 A4 20110413; JP 5106098 B2 20121226; JP WO2006090931 A1 20080724; US 2009047365 A1 20090219; WO 2006090931 A1 20060831
DOCDB simple family (application)
EP 06715262 A 20060228; JP 2006304219 W 20060228; JP 2007504858 A 20060228; US 88512906 A 20060228